A low haemoglobin count, older age and high BMI are possible risk factors for developing nerve damage after cancer treatment, a UNSW-led study has found.
German and Australian scientists have discovered a molecule able to silence pain receptors under the skin, giving new hope to millions of people living with the devastating effects of diabetic neuropathy.
Understanding how chemotherapy-induced nerve damage impacts on the quality of life of Australia’s cancer survivors is the goal of a new survey launched by UNSW.
